Filed: 5/15/2023ACC: 0001013594-23-000495
📋 What this filing means
ISZO CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $18.81M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$18.81M
Total AUM (reported)
559.83K
Total Shares
Allocation by class
COM$11.01M58.5%
COMMON STOCK$2.10M11.2%
SPONSORED ADR$2.02M10.8%
UNIT SER 1$1.54M8.2%
ADR$1.11M5.9%
TR UNIT$1.02M5.4%
SHS$0.000.0%
Portfolio Concentration
Top 3$12.38M65.8%
4–10$6.43M34.2%
Top 3 weight
65.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 559.83K
Sole
Full voting authority
559.83K
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole10
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings10
Rows:
LANTHEUS HLDGS INC
SOLEShares100K
TypeSH
Market value$8.26M
43.89%
Sole
100K
Shared
0.00
None
0.00
CBL & ASSOC PPTYS INC
SOLEShares82.08K
TypeSH
Market value$2.10M
11.19%
Sole
82.08K
Shared
0.00
None
0.00
NOVARTIS AG
SOLEShares22K
TypeSH
Market value$2.02M
10.76%
Sole
22K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares9K
TypeSH
Market value$2.02M
10.71%
Sole
9K
Shared
0.00
None
0.00
INVESCO QQQ TR
SOLEShares4.80K
TypeSH
Market value$1.54M
8.19%
Sole
4.80K
Shared
0.00
None
0.00
NOVO-NORDISK A S
SOLEShares7K
TypeSH
Market value$1.11M
5.92%
Sole
7K
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares2.50K
TypeSH
Market value$1.02M
5.44%
Sole
2.50K
Shared
0.00
None
0.00
FIRST REP BK SAN FRANCISCO C
SOLEShares52K
TypeSH
Market value$727.5K
3.87%
Sole
52K
Shared
0.00
None
0.00
AMPLIFY ENERGY CORP NEW
SOLEShares953.00
TypeSH
Market value$6.5K
0.03%
Sole
953.00
Shared
0.00
None
0.00
GLOBAL CORD BLOOD CORPORATIO
SOLEShares279.50K
TypeSH
Market value$0.00
<0.01%
Sole
279.50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LANTHEUS HLDGS INCSOLE | COM | 100K | SH | $8.26M 43.89% | 100K | 0.00 | 0.00 |
CBL & ASSOC PPTYS INCSOLE | COMMON STOCK | 82.08K | SH | $2.10M 11.19% | 82.08K | 0.00 | 0.00 |
NOVARTIS AGSOLE | SPONSORED ADR | 22K | SH | $2.02M 10.76% | 22K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 9K | SH | $2.02M 10.71% | 9K | 0.00 | 0.00 |
INVESCO QQQ TRSOLE | UNIT SER 1 | 4.80K | SH | $1.54M 8.19% | 4.80K | 0.00 | 0.00 |
NOVO-NORDISK A SSOLE | ADR | 7K | SH | $1.11M 5.92% | 7K | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 2.50K | SH | $1.02M 5.44% | 2.50K | 0.00 | 0.00 |
FIRST REP BK SAN FRANCISCO CSOLE | COM | 52K | SH | $727.5K 3.87% | 52K | 0.00 | 0.00 |
AMPLIFY ENERGY CORP NEWSOLE | COM | 953.00 | SH | $6.5K 0.03% | 953.00 | 0.00 | 0.00 |
GLOBAL CORD BLOOD CORPORATIOSOLE | SHS | 279.50K | SH | $0.00 <0.01% | 279.50K | 0.00 | 0.00 |